MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  
cancer and oncology image

Cancer Drugs & Oncology Drugs

Prescription drugs for the medical, surgical, and radiation treatment of tumors (cancerous, especially). Studies in this area include most types of cancer and treatment thereof.

The list of FDA approved drugs for cancer and oncology appears below. Click any link to view the full drug information.


Bookmark and Share
Number Of Cancer Drugs & Oncology Drugs: 167

Abraxane (paclitaxel protein-bound particles for injectable suspension)
For the treatment of non-small cell lung cancer
Abstral (fentanyl sublingual tablets)
For the treatment of breakthrough cancer pain in opioid-tolerant patients
Actiq
Treatment for Cancer Pain
Adcetris (brentuximab vedotin)
For the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma
Afinitor (everolimus)
For the treatment of renal cell carcinoma
Afinitor (everolimus)
For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex
Afinitor (everolimus)
For the treatment of advanced pancreatic neuroendocrine tumors
Afinitor (everolimus)
For the treatment of hormone receptor-positive, HER2-negative breast cancer
Alimta (pemetrexed for injection)
For the treatment of malignant pleural mesothelioma
Aloxi (palonosetron)
For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy
Anexsia
Treatment for chronic pain
Anzemet
Treatment for the prevention of nausea and vomiting associated with chemotherapy and surgery
Anzemet
Treatment for emesis
Aredia (pamidronate disodium for injection)
Treatment for osteolytic bone metastases of breast cancer
Arimidex (anastrozole)
Treatment for advanced breast cancer in postmenopausal women
Aromasin Tablets
Exemestane Tablets, 25 mg
Arranon (nelarabine)
For the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Arzerra (ofatumumab)
For the treatment of chronic lymphocytic leukemia
Avastin (bevacizumab)
For the treatment of renal cell carcinoma
Avastin (bevacizumab)
For the treatment of metastatic carcinoma of the colon or rectum
Bexxar
For the treatment of patients with CD20 positive, follicular, non-Hodgkin's lymphoma following chemotherapy relapse
Bosulif (bosutinib)
For the treatment of Ph+ chronic myelogenous leukemia
Bromfenac
Management of acute pain
Busulflex
For use in combination for the treatment of leukemia
Campath
Injectable treatment of B-cell chronic lymphocytic leukemia
Campostar
Treatment for metastatic colorectal cancer
Camptosar
Treatment for Colon or Rectal Cancer
CEA-Scan
Diagnostic imaging product for colorectal cancer
Cervarix [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant
For the prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18
Clolar (clofarabine)
For the treatment of acute lymphoblastic leukemia in pediatric patients
Cometriq (cabozantinib)
For the treatment of metastatic medullary thyroid cancer
Degarelix (degarelix for injection)
For the treatment of prostate cancer
Doxil (doxorubicin HCl liposome injection)
Treatment for ovarian cancer that is refractory to other first-line therapies
Eligard (leuprolide acetate)
For the palliative treatment of advanced prostate cancer
Elitek (rasburicase)
For the management of plasma uric acid levels in adults with malignancies
Ellence
epirubicin hydrochloride
Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection)
Treatment of meningeal leukemia or lymphocytic lymphoma
Eloxatin (oxaliplatin/5-fluorouracil/leucovorin)
For the treatment of colon or rectum carcinomas
Emend (aprepitant)
For the treatment of nausea and vomiting associated with chemotherapy
Erbitux (cetuximab)
For the treatment of EGFR-expressing, metastatic colorectal cancer
Erivedge (vismodegib)
For the treatment of basal cell carcinoma
Erwinaze (asparaginase Erwinia chrysanthemi)
For the treatment of acute lymphoblastic leukemia
Ethyol (amifostine)
Treatment for xerostomia (dry mouth) due to radiation
Ethyol (amifostine)
Treatment to reduce renal toxicity associated with chemotherapy in subjects with advanced ovarian cancer
Eulexin (flutamide)
Treatment for prostate cancer
Evista (raloxifene hydrochloride)
For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women
Faslodex (fulvestrant)
For the treatment of hormone receptor positive metastatic breast cancer
Femara (letrozole)
First-line treatment of postmenopausal women with locally advanced or metastatic breast cancer
Femara (letrozole)
Treatment for breast cancer
Feridex I.V.
Contrast agent for magnetic resonance imaging of liver lesions
Folotyn (pralatrexate injection)
For the treatment of peripheral T-cell lymphoma
Fusilev (levoleucovorin)
For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate
Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)
For the prevention of cervical cancer associated with human papillomavirus
GastroMARK
Contrast agent for magnetic resonance imaging of the gastrointestinal tract
Gazyva (obinutuzumab)
For the treatment of previously untreated chronic lymphocytic leukemia
Gemzar (gemcitabine HCL)
Treatment for pancreatic cancer
Gemzar (gemcitabine HCL)
Treatment for Lung Cancer
Gilotrif (afatinib)
For the treatment of metastatic non-small cell lung cancer with EGFR mutations
Gleevec (imatinib mesylate)
Oral therapy for the treatment of chronic myeloid leukemia
Gleevec (imatinib mesylate)
For the treatment of gastrointestinal stromal tumors (GISTs)
Halaven (eribulin mesylate)
For the treatment of metastatic breast cancer
Herceptin
Treatment for metastatic breast cancer
Herceptin (trastuzumab)
For the treatment of gastric cancer
Hycamtin (topotecan hydrochloride)
For the treatment of small cell lung cancer
Hycamtin (topotecan hydrochloride)
Treatment for metastatic ovarian cancer
Iclusig (ponatinib)
For the treatment of chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia
Imbruvica (ibrutinib)
For the treatment of mantle cell lymphoma
Imbruvica (ibrutinib)
For the treatment of chronic lymphocytic leukemia
Inform HER-2/neu breast cancer test
Treatment for breast cancer prediction
Inlyta (axitinib)
For the treatment of advanced renal cell carcinoma
Intron A (interferon alfa-2b, recombinant)
Treatment for non-Hodgkin's lymphoma
Intron A (Interferon alfa-2b, recombinant)
An adjuvant treatment to surgery in subjects at high risk for systemic recurrence of malignant melanoma
Iressa (gefitinib)
For the second-line treatment of non-small-cell lung cancer
Istodax (romidepsin)
For the treatment of cutaneous T-cell lymphoma
Ixempra (ixabepilone)
For the treatment of breast cancer
Jevtana (cabazitaxel)
For the treatment of prostate cancer
Kadcyla (ado-trastuzumab emtansine)
For the treatment of HER2-positive metastatic breast cancer
Kadian
Treatment for chronic moderate to severe pain
Kyprolis (carfilzomib)
For the treatment of multiple myeloma
Kytril (granisetron) solution
For the prevention of nausea and vomiting associated with cancer therapy
Kytril (granisetron) tablets
Prevention of nausea and vomiting associated with chemotherapy
Lazanda (fentanyl citrate) nasal spray
For the management of breakthrough cancer pain
Leukine (sargramostim)
Treatment for the replenishment of white blood cells
Leukine (sargramostim)
Treatment for mobilizing peripheral blood progenitor cells for use after transplantation.
Lupron Depot (leuprolide acetate for depot suspension)
Treatment for advanced prostate cancer
Marqibo (vinCRIStine sulfate LIPOSOME injection)
For the treatment of Ph- acute lymphoblastic leukemia
Mekinist (trametinib)
For the treatment of unresectable or metastatic melanoma with BRAF V600E or V600K mutations
Miraluma test
Test for breast cancer
Mozobil (plerixafor injection)
For the treatment of non-Hodgkin’s lymphoma and multiple myeloma
Mylotarg (gemtuzumab ozogamicin)
For the treatment of CD33 positive acute myeloid leukemia (AML)
Neulasta
Treatment to decrease the chance of infection by febrile neutropenia in patients receiving chemotherapy
Neumega
Treatment for thrombocytopenia
Neupogen
Treatment for slow white blood cell recovery following chemotherapy
Neutroval (tbo-filgrastim)
For the reduction in the duration of severe chemotherapy-induced neutropenia
Nexavar (sorafenib)
For the Treatment of Renal Cell Carcinoma
Nolvadex
Treatment for Breast Cancer
Onsolis (fentanyl buccal)
For the management of breakthrough cancer pain
Perjeta (pertuzumab)
For the first-line treatment of HER2+ metastatic breast cancer
Photodynamic Therapy
Photodynamic therapy device for the treatment of esophageal cancer
Photofrin
Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer
Picato (ingenol mebutate) gel
For the treatment of actinic keratosis
Plenaxis (abarelix for injectable suspension)
For treatment of advanced prostate cancer
Pomalyst (pomalidomide)
For the treatment of relapsed and refractory multiple myeloma
Premarin (conjugated estrogens)
For the prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms
Proleukin
Treatment for metastatic melanoma
Provenge (sipuleucel-T)
For the treatment of hormone refractory prostate cancer
Quadramet (Samarium Sm 153 Lexidronam Injection)
Treatment for pain associated with bone cancer
Revlimid (lenalidomide)
For the treatment of mantle cell lymphoma
Rituxan
Treatment for non-hodgkin's lymphoma
Sancuso (granisetron)
For the treatment of chemotherapy-induced nausea and vomiting
Sclerosol Intrapleural Aerosol
Treatment for malignant pleural effusions
SecreFlo (secretin)
To aid in the diagnosis of pancreatic dysfunction and gastrinoma
Self-examination breast pad
Self-examination breast pad
Sensipar (cinacalcet)
For the treatment of secondary hyperparathyroidism and hypercalcemia in parathyroid carcinoma patients
Sprycel (dasatinib)
For the treatment of imatinib-resistant chronic myeloid leukemia
Stivarga (regorafenib)
For the treatment of gastrointestinal stromal tumor
Stivarga (regorafenib)
For the treatment of previously treated patients with metastatic colorectal cancer
Subsys (fentanyl sublingual spray)
For the treatment of breakthrough cancer pain
Sutent (sunitinib malate)
For the treatment of pancreatic neuroendocrine tumors
Sutent (sunitinib)
For the treatment of kidney cancer and gastrointestinal stromal tumors
Sylatron (peginterferon alfa-2b)
For the treatment of melanoma
Synercid I.V.
quinupristin and dalfopristin for injection
Synribo (omacetaxine mepesuccinate)
For the treatment of chronic or accelerated phase chronic myeloid leukemia
Tafinlar (dabrafenib)
For the treatment of unresectable or metastatic melanoma with BRAF V600E mutation
Tarceva (erlotinib, OSI 774)
For the treatment of advanced refractory metastatic non-small cell lung cancer
Tasigna (nilotinib hydrochloride monohydrate)
For the treatment of chronic myelogenous leukemia
Taxol
Treatment for AIDS-related Kaposi's Sarcoma
Taxotere (Docetaxel)
Treatment for locally advanced or metastatic breast cancer
Temodar
Treatment for refractory anaplastic astrocytoma
Torisel (temsirolimus)
For the treatment of renal cell carcinoma
Treanda (bendamustine hydrochloride)
For the treatment of Chronic lymphocytic leukemia and B-cell non-Hodgkin’s lymphoma
Trelstar Depot (triptorelin pamoate)
For the palliative treatment of advanced prostate cancer
Trelstar LA (triptorelin pamoate)
Intramuscular injection for the treatment of advanced stage prostate cancer
Trisenox (arsenic trioxide)
For the induction of remission and consolidation in patients with acute promyelocytic leukemia (APL)
Tykerb (lapatinib)
For the treatment of breast cancer
UltraJect
Treatment for chronic pain
UroXatral (alfuzosin HCl extended-release tablets)
For the treatment of of the signs and symptoms of benign prostatic hyperplasia
UVADEX Sterile Solution
Treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL)
Valchlor (mechlorethamine) gel
For the treatment of Stage IA/IB mycosisfungoides-type cutaneous T-cell lymphoma
Valstar
Treatment for Bladder Cancer
Vandetanib (vandetanib)
For the treatment of thyroid cancer
Vectibix (panitumumab)
For the treatment of colorectal cancer
Velcade (bortezomib)
Injectable agent for the treatment of multiple myeloma patients who have received at least two prior therapies.
Viadur (leuprolide acetate implant)
For pain relief in men with advanced prostate cancer
Visipaque (iodixanol)
Diagnostic contrast agent
Votrient (pazopanib)
For the treatment of soft tissue sarcoma
Votrient (pazopanib)
For the treatment of renal cell carcinoma
Xalkori (crizotinib)
For the treatment of ALK+ non-small cell lung cancer
Xeloda
Treatment for advanced breast cancer tumors
Xeloda
Oral chemotherapy for the treatment of metastatic colorectal cancer
Xgeva (denosumab)
For the treatment of giant cell tumor of bone
Xgeva (denosumab)
For the prevention of skeletal-related events in patients with bone metastases from solid tumors
Xofigo (radium Ra 223 dichloride)
For the treatment of prostate cancer with bone metastases
Xtandi (enzalutamide)
For the treatment of metastatic castration-resistant prostate cancer
Yervoy (ipilimumab)
For the treatment of metastatic melanoma
Zaltrap (ziv-aflibercept)
For the treatment of metastatic colorectal cancer
Zelboraf (vemurafenib)
For the treatment of BRAF + melanoma
Zevalin (ibritumomab tiuxetan)
For the treatment of non-Hodgkin's lymphoma
Zofran
Treatment for the prevention of chemotherapy and radiation-induced nausea
Zofran
Treatment for postoperative vomiting and nausea in adults
Zoladex (10.8 mg goserelin acetate implant)
Treatment for advanced prostate cancer
Zometa (zoledronic acid)
For the treatment of hypercalcemia of malignancy
Zometa (zoledronic acid)
For the treatment of multiple myeloma and bone metastases from solid tumors
Zuplenz (ondansetron oral soluble film)
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting
Zytiga (abiraterone acetate)
For the treatment of prostate cancer


« back to top
FDA Approved Cancer Drugs & Oncology Drugs Listings:

The rules of principle for evaluating MediLexicon's FDA cancer drugs & oncology drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

MediLexicon's FDA Approved Drugs Listings include:

New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

MediLexicon's FDA Approved Drugs Listings do NOT include:

Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.

The cancer drugs & oncology drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.






MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.